Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 1 day agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 2 hours agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Moderna and OpenAI Collaborate To Advance mRNA Medicine
San Mateo Daily Journal· 2 hours agoCAMBRIDGE, MA AND SAN FRANCISCO, CA / ACCESSWIRE / April 24, 2024 / Moderna, Inc. (NASDAQ:MRNA) and OpenAI today announced their ongoing collaboration to co-innovate with ...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 8 hours agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses but also ...
At Moderna, OpenAI’s GPTs Are Changing Almost Everything
The Wall Street Journal· 4 hours ago“People literally talk about how AI is going to cure diseases someday, and I think this is a very...
... in London Patent Battle over Covid-19 Vaccines In Legal Showdown - Moderna (NASDAQ:MRNA), Pfizer...
Benzinga· 20 hours agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 2 days agoThe agreement comes on the heels of the Brazilian Health Regulatory Agency's approval of the vaccine...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 1 day agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape· 10 hours agoMany clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary.